Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 45 min ago
PreprintAll rights reservedmedRxiv

Convergent mutational processes in esophageal and junctional adenocarcinomas across eight countries

  • L. Torrens
  • S. Moody
  • J. Pang
  • B. Abedi-Ardekani
  • H. Zhang
  • A. Abbasi
  • C. Nunn
  • S. Fitzgerald
  • P. Gallego-Garcia
  • V. Gaborieau
  • T. Cattiaux
  • P. Chopard
25 more authors
  • S. Cheema
  • E. Thomas
  • C. Latimer
  • C. Carreira
  • M. Diaz-Gay
  • M. P. Curado
  • C. Dzamalala
  • F. Fermandes Coimbra
  • L. Ferri
  • R. C. Fitzgerald
  • A. M. Goldstein
  • A. Huertas-Salgado
  • R. Malekzadeh
  • D. Menya
  • R. M. Reis
  • F. Ribeiro Pinto
  • G. Roshandel
  • J. Yeung
  • A. C. de Carvalho
  • L. Humphreys
  • A. Noorani
  • L. B. Alexandrov
  • P. Brennan
  • M. R. Stratton
  • S. Perdomo1
  1. 1International Agency for Research on Cancer (IARC/WHO)
Read full textPDFDOICite

Related

  1. Hyper-mutational processes provide a head-start for weak cancer drivers: Explaining atypical KRAS variants
    Michael D Nicholson, Ian Tomlinson
    PLOS Computational BiologyPeer-reviewedCC BYFull textGenetics & genomicsOncologyPLOSEurope PMC
  2. Clinicopathological Significance of Extra‐Alveolar Invasion in Lung Adenocarcinomas Treated With Sublobar Resection
    Masaki Suzuki, Aya Shinozaki‐Ushiku, Junichi Takada +6
    Pathology internationalPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.
    Anne Mc Leer, Matthieu Foll, Marie Brevet +12
    Lung CancerPeer-reviewedLicence not stated20 citedGeneral biologyOncologyHAL
  4. The impact of STAS on recurrence-free and overall survival in T1-2N0 adenocarcinomas: a single-center retrospective study
    Şebnem Dursun, Saliha Yılmaz, Yusuf Kahya +6
    BMC CancerPeer-reviewedCC BYFull textOncologyDOAJ
  5. Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK‐positive anaplastic large‐cell lymphoma
    Jietian Jin, Wenjian Cen, Qin Yan +4
    HistopathologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC

Cite

BibTeXRIS
BibTeX
@misc{torrens2026convergent,
  title = {{Convergent mutational processes in esophageal and junctional adenocarcinomas across eight countries}},
  author = {L. Torrens and S. Moody and J. Pang and B. Abedi-Ardekani and H. Zhang and A. Abbasi and C. Nunn and S. Fitzgerald and P. Gallego-Garcia and V. Gaborieau and T. Cattiaux and P. Chopard and S. Cheema and E. Thomas and C. Latimer and C. Carreira and M. Diaz-Gay and M. P. Curado and C. Dzamalala and F. Fermandes Coimbra and L. Ferri and R. C. Fitzgerald and A. M. Goldstein and A. Huertas-Salgado and R. Malekzadeh and D. Menya and R. M. Reis and F. Ribeiro Pinto and G. Roshandel and J. Yeung and A. C. de Carvalho and L. Humphreys and A. Noorani and L. B. Alexandrov and P. Brennan and M. R. Stratton and S. Perdomo},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.21.26365720},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.21.26365720v1},
}
RIS
TY  - UNPB
TI  - Convergent mutational processes in esophageal and junctional adenocarcinomas across eight countries
AU  - L. Torrens
AU  - S. Moody
AU  - J. Pang
AU  - B. Abedi-Ardekani
AU  - H. Zhang
AU  - A. Abbasi
AU  - C. Nunn
AU  - S. Fitzgerald
AU  - P. Gallego-Garcia
AU  - V. Gaborieau
AU  - T. Cattiaux
AU  - P. Chopard
AU  - S. Cheema
AU  - E. Thomas
AU  - C. Latimer
AU  - C. Carreira
AU  - M. Diaz-Gay
AU  - M. P. Curado
AU  - C. Dzamalala
AU  - F. Fermandes Coimbra
AU  - L. Ferri
AU  - R. C. Fitzgerald
AU  - A. M. Goldstein
AU  - A. Huertas-Salgado
AU  - R. Malekzadeh
AU  - D. Menya
AU  - R. M. Reis
AU  - F. Ribeiro Pinto
AU  - G. Roshandel
AU  - J. Yeung
AU  - A. C. de Carvalho
AU  - L. Humphreys
AU  - A. Noorani
AU  - L. B. Alexandrov
AU  - P. Brennan
AU  - M. R. Stratton
AU  - S. Perdomo
PY  - 2026
DA  - 2026/10/21
PB  - medRxiv
DO  - 10.64898/2026.10.21.26365720
UR  - https://www.medrxiv.org/content/10.64898/2026.10.21.26365720v1
ER  -